The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Acetic acid 1-[2-(4-ethylsulfanyl-3-methyl-pyridin-2-ylmethanesulfinyl)-benzoimidazol-1-yl]-ethyl ester ID: ALA10013
PubChem CID: 14894172
Max Phase: Preclinical
Molecular Formula: C20H23N3O3S2
Molecular Weight: 417.56
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCSc1ccnc(C[S+]([O-])c2nc3ccccc3n2C(C)OC(C)=O)c1C
Standard InChI: InChI=1S/C20H23N3O3S2/c1-5-27-19-10-11-21-17(13(19)2)12-28(25)20-22-16-8-6-7-9-18(16)23(20)14(3)26-15(4)24/h6-11,14H,5,12H2,1-4H3
Standard InChI Key: BANYVCVZKRCIQR-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
5.1380 -3.3971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2216 -4.2251 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8932 -3.0602 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4169 -2.9874 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.6104 -4.7835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0341 -4.3977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4511 -3.6807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6952 -3.4011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9762 -2.9877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7776 -5.5916 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9846 -2.1590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1664 -6.1500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2618 -3.4056 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4123 -2.1561 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2656 -1.7456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3734 -5.8922 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2703 -0.9149 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.5448 -2.9886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5454 -2.1651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8174 -4.5257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4593 -5.1162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7021 -1.7525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2787 -3.6740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3408 -6.9622 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5513 -0.5014 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2869 -5.1096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5524 0.3314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6966 -4.3885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 2 0
4 1 1 0
5 2 1 0
6 2 1 0
7 3 1 0
8 4 1 0
9 8 1 0
10 5 1 0
11 9 1 0
12 10 1 0
13 9 2 0
14 4 1 0
15 11 2 0
16 12 2 0
17 15 1 0
18 13 1 0
19 18 2 0
20 5 1 0
21 6 2 0
22 11 1 0
23 7 2 0
24 12 1 0
25 17 1 0
26 21 1 0
27 25 1 0
28 23 1 0
6 7 1 0
26 28 2 0
19 15 1 0
M CHG 2 4 1 14 -1
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 417.56Molecular Weight (Monoisotopic): 417.1181AlogP: 4.24#Rotatable Bonds: 7Polar Surface Area: 80.07Molecular Species: NEUTRALHBA: 7HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.12CX Basic pKa: 2.86CX LogP: 3.43CX LogD: 3.43Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.32Np Likeness Score: -0.67
References 1. Sih JC, Im WB, Robert A, Graber DR, Blakeman DP.. (1991) Studies on (H(+)-K+)-ATPase inhibitors of gastric acid secretion. Prodrugs of 2-[(2-pyridinylmethyl)sulfinyl]benzimidazole proton-pump inhibitors., 34 (3): [PMID:1848293 ] [10.1021/jm00107a026 ] 2. Sih JC, Im WB, Robert A, Graber DR, Blakeman DP.. (1991) Studies on (H(+)-K+)-ATPase inhibitors of gastric acid secretion. Prodrugs of 2-[(2-pyridinylmethyl)sulfinyl]benzimidazole proton-pump inhibitors., 34 (3): [PMID:1848293 ] [10.1021/jm00107a026 ]